Magenta Therapeutics, Inc is a biotechnology business based in the US. Magenta Therapeutics shares (MGTA) are listed on the NASDAQ and all prices are listed in US Dollars. Magenta Therapeutics employs 67 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Magenta Therapeutics
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – MGTA – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Magenta Therapeutics stock price (NASDAQ: MGTA)Use our graph to track the performance of MGTA stocks over time.
Magenta Therapeutics shares at a glance
|Latest market close||$12.35|
|52-week range||$6.03 - $14.20|
|50-day moving average||$10.23|
|200-day moving average||$10.81|
|Wall St. target price||$19.50|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.91|
Buy Magenta Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Magenta Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Magenta Therapeutics price performance over time
|1 week (2021-07-16)||N/A|
|1 month (2021-06-25)||24.25%|
|3 months (2021-04-27)||7.30%|
|6 months (2021-01-23)||N/A|
|1 year (2020-07-23)||N/A|
|2 years (2019-07-23)||N/A|
|3 years (2018-07-23)||N/A|
|5 years (2016-07-23)||N/A|
Magenta Therapeutics financials
|Gross profit TTM||$0|
|Return on assets TTM||-32.93%|
|Return on equity TTM||-56.92%|
|Market capitalisation||$439.4 million|
TTM: trailing 12 months
Shorting Magenta Therapeutics shares
There are currently 1.6 million Magenta Therapeutics shares held short by investors – that's known as Magenta Therapeutics's "short interest". This figure is 1.4% up from 1.6 million last month.
There are a few different ways that this level of interest in shorting Magenta Therapeutics shares can be evaluated.
Magenta Therapeutics's "short interest ratio" (SIR)
Magenta Therapeutics's "short interest ratio" (SIR) is the quantity of Magenta Therapeutics shares currently shorted divided by the average quantity of Magenta Therapeutics shares traded daily (recently around 253773.02839117). Magenta Therapeutics's SIR currently stands at 6.34. In other words for every 100,000 Magenta Therapeutics shares traded daily on the market, roughly 6340 shares are currently held short.
However Magenta Therapeutics's short interest can also be evaluated against the total number of Magenta Therapeutics shares, or, against the total number of tradable Magenta Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Magenta Therapeutics's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Magenta Therapeutics shares in existence, roughly 30 shares are currently held short) or 0.0546% of the tradable shares (for every 100,000 tradable Magenta Therapeutics shares, roughly 55 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Magenta Therapeutics.
Find out more about how you can short Magenta Therapeutics stock.
Magenta Therapeutics share dividends
We're not expecting Magenta Therapeutics to pay a dividend over the next 12 months.
Magenta Therapeutics share price volatility
Over the last 12 months, Magenta Therapeutics's shares have ranged in value from as little as $6.03 up to $14.2. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Magenta Therapeutics's is 2.3583. This would suggest that Magenta Therapeutics's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Magenta Therapeutics overview
Magenta Therapeutics, Inc. , a clinical-stage biotechnology company, develops novel medicines to bring the curative power of stem cell transplant, gene therapy, genome editing, and cell therapy to patients. The company is developing C100 and C300 targeted antibody-drug conjugates for transplant conditioning; MGTA-145, a stem cell mobilization product candidate to control stem cell mobilization; MGTA-456, an allogeneic stem cell therapy to control stem cell growth; E478, a small molecule aryl hydrocarbon receptor antagonist for the expansion of gene-modified stem cells; and G100, an antibody-drug conjugate program to prevent prophylaxis of graft-versus-host diseases. It has a has a research and clinical collaboration agreement with AVROBIO, Inc. to evaluate potential utility of MGTA-117 for conditioning of patients receiving one or more investigational lentiviral gene therapies; and clinical trial collaboration with bluebird bio, Inc. to evaluate the utility of MGTA-145, in combination with plerixafor, for mobilization and collection of stem cells in adults and adolescents with sickle cell disease. The company was formerly known as HSCTCo Therapeutics, Inc.
Stocks similar to Magenta Therapeutics
Magenta Therapeutics in the news
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Magenta Therapeutics, Inc. - MGTA
MGTA Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Magenta Therapeutics, Inc. Investigation
2 “Strong Buy” Stocks Under $10 With Strong Growth Prospects
Frequently asked questionsWhat percentage of Magenta Therapeutics is owned by insiders or institutions?
Currently 8.716% of Magenta Therapeutics shares are held by insiders and 70.237% by institutions. How many people work for Magenta Therapeutics?
Latest data suggests 67 work at Magenta Therapeutics. When does the fiscal year end for Magenta Therapeutics?
Magenta Therapeutics's fiscal year ends in December. Where is Magenta Therapeutics based?
Magenta Therapeutics's address is: 100 Technology Square, Cambridge, MA, United States, 02139 What is Magenta Therapeutics's ISIN number?
Magenta Therapeutics's international securities identification number is: US55910K1088 What is Magenta Therapeutics's CUSIP number?
Magenta Therapeutics's Committee on Uniform Securities Identification Procedures number is: 55910K108
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy Hellenic Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert